U
Brain Scientific Inc.
BRSF
$0.75
-$0.35-31.82%
E
Sell
3/15/2024Downgrade
Brain Scientific Inc. (BRSF) was downgraded to E from E+ on 3/15/2024 due to a decline in the volatility index.
Brain Scientific Inc. (BRSF) was downgraded to E from E+ on 3/15/2024 due to a decline in the volatility index.
E
Sell
2/27/2024Upgraded
Brain Scientific Inc. (BRSF) was upgraded to E+ from E on 2/27/2024 due to an increase in the volatility index and total return index.
Brain Scientific Inc. (BRSF) was upgraded to E+ from E on 2/27/2024 due to an increase in the volatility index and total return index.
E
Sell
2/8/2024Downgrade
Brain Scientific Inc. (BRSF) was downgraded to E from E+ on 2/8/2024 due to a decline in the volatility index, growth index and total return index.
Brain Scientific Inc. (BRSF) was downgraded to E from E+ on 2/8/2024 due to a decline in the volatility index, growth index and total return index.
E
Sell
1/22/2024Upgraded
Brain Scientific Inc. (BRSF) was upgraded to E+ from E on 1/22/2024 due to an increase in the volatility index and total return index.
Brain Scientific Inc. (BRSF) was upgraded to E+ from E on 1/22/2024 due to an increase in the volatility index and total return index.
E
Sell
1/4/2024Downgrade
Brain Scientific Inc. (BRSF) was downgraded to E from E+ on 1/4/2024 due to a decline in the volatility index.
Brain Scientific Inc. (BRSF) was downgraded to E from E+ on 1/4/2024 due to a decline in the volatility index.
E
Sell
12/13/2023Upgraded
Brain Scientific Inc. (BRSF) was upgraded to E+ from E on 12/13/2023 due to an increase in the volatility index and total return index.
Brain Scientific Inc. (BRSF) was upgraded to E+ from E on 12/13/2023 due to an increase in the volatility index and total return index.
E
Sell
11/27/2023Downgrade
Brain Scientific Inc. (BRSF) was downgraded to E from E+ on 11/27/2023 due to a decline in the volatility index.
Brain Scientific Inc. (BRSF) was downgraded to E from E+ on 11/27/2023 due to a decline in the volatility index.
E
Sell
11/9/2023Upgraded
Brain Scientific Inc. (BRSF) was upgraded to E+ from E on 11/9/2023 due to an increase in the volatility index and total return index.
Brain Scientific Inc. (BRSF) was upgraded to E+ from E on 11/9/2023 due to an increase in the volatility index and total return index.
E
Sell
7/18/2023Downgrade
Brain Scientific Inc. (BRSF) was downgraded to E from E+ on 7/18/2023 due to a decline in the volatility index.
Brain Scientific Inc. (BRSF) was downgraded to E from E+ on 7/18/2023 due to a decline in the volatility index.
E
Sell
6/30/2023Upgraded
Brain Scientific Inc. (BRSF) was upgraded to E+ from E on 6/30/2023 due to an increase in the volatility index.
Brain Scientific Inc. (BRSF) was upgraded to E+ from E on 6/30/2023 due to an increase in the volatility index.
E
Sell
6/13/2023Downgrade
Brain Scientific Inc. (BRSF) was downgraded to E from E+ on 6/13/2023 due to a decline in the volatility index.
Brain Scientific Inc. (BRSF) was downgraded to E from E+ on 6/13/2023 due to a decline in the volatility index.
E
Sell
5/26/2023Upgraded
Brain Scientific Inc. (BRSF) was upgraded to E+ from E on 5/26/2023 due to an increase in the volatility index.
Brain Scientific Inc. (BRSF) was upgraded to E+ from E on 5/26/2023 due to an increase in the volatility index.
E
Sell
5/11/2023Downgrade
Brain Scientific Inc. (BRSF) was downgraded to E from E+ on 5/11/2023 due to a decline in the volatility index, growth index and total return index.
Brain Scientific Inc. (BRSF) was downgraded to E from E+ on 5/11/2023 due to a decline in the volatility index, growth index and total return index.
E
Sell
4/26/2023Upgraded
Brain Scientific Inc. (BRSF) was upgraded to E+ from E on 4/26/2023 due to an increase in the volatility index.
Brain Scientific Inc. (BRSF) was upgraded to E+ from E on 4/26/2023 due to an increase in the volatility index.
E
Sell
4/11/2023Downgrade
Brain Scientific Inc. (BRSF) was downgraded to E from E+ on 4/11/2023 due to a decline in the solvency index and volatility index. Debt to equity increased from 0.28 to 0.66, and the quick ratio declined from 0.3 to 0.1.
Brain Scientific Inc. (BRSF) was downgraded to E from E+ on 4/11/2023 due to a decline in the solvency index and volatility index. Debt to equity increased from 0.28 to 0.66, and the quick ratio declined from 0.3 to 0.1.
E
Sell
4/4/2023Upgraded
Brain Scientific Inc. (BRSF) was upgraded to E+ from E on 4/4/2023 due to an increase in the volatility index.
Brain Scientific Inc. (BRSF) was upgraded to E+ from E on 4/4/2023 due to an increase in the volatility index.
E
Sell
3/20/2023Downgrade
Brain Scientific Inc. (BRSF) was downgraded to E from E+ on 3/20/2023 due to a decline in the volatility index and total return index.
Brain Scientific Inc. (BRSF) was downgraded to E from E+ on 3/20/2023 due to a decline in the volatility index and total return index.
E
Sell
2/23/2023Upgraded
Brain Scientific Inc. (BRSFD) was upgraded to E+ from E on 2/23/2023 due to a noticeable increase in the valuation index and growth index.
Brain Scientific Inc. (BRSFD) was upgraded to E+ from E on 2/23/2023 due to a noticeable increase in the valuation index and growth index.
E
Sell
2/8/2023Downgrade
Brain Scientific Inc. (BRSFD) was downgraded to E from D- on 2/8/2023 due to a noticeable decline in the valuation index and volatility index.
Brain Scientific Inc. (BRSFD) was downgraded to E from D- on 2/8/2023 due to a noticeable decline in the valuation index and volatility index.
D
Sell
1/31/2023Upgraded
Brain Scientific Inc. (BRSF) was upgraded to D- from E+ on 1/31/2023 due to an increase in the volatility index and total return index.
Brain Scientific Inc. (BRSF) was upgraded to D- from E+ on 1/31/2023 due to an increase in the volatility index and total return index.
E
Sell
1/11/2023Downgrade
Brain Scientific Inc. (BRSF) was downgraded to E+ from D- on 1/11/2023 due to a decline in the volatility index and total return index.
Brain Scientific Inc. (BRSF) was downgraded to E+ from D- on 1/11/2023 due to a decline in the volatility index and total return index.
D
Sell
12/27/2022Upgraded
Brain Scientific Inc. (BRSF) was upgraded to D- from E+ on 12/27/2022 due to an increase in the volatility index and total return index.
Brain Scientific Inc. (BRSF) was upgraded to D- from E+ on 12/27/2022 due to an increase in the volatility index and total return index.
E
Sell
12/9/2022Downgrade
Brain Scientific Inc. (BRSF) was downgraded to E+ from D- on 12/9/2022 due to a noticeable decline in the solvency index and volatility index. Debt to equity increased from 0.17 to 0.28, and the quick ratio declined from 0.53 to 0.3.
Brain Scientific Inc. (BRSF) was downgraded to E+ from D- on 12/9/2022 due to a noticeable decline in the solvency index and volatility index. Debt to equity increased from 0.17 to 0.28, and the quick ratio declined from 0.53 to 0.3.
D
Sell
11/10/2022Upgraded
Brain Scientific Inc. (BRSF) was upgraded to D- from E+ on 11/10/2022 due to an increase in the volatility index.
Brain Scientific Inc. (BRSF) was upgraded to D- from E+ on 11/10/2022 due to an increase in the volatility index.
E
Sell
10/26/2022Downgrade
Brain Scientific Inc. (BRSF) was downgraded to E+ from D- on 10/26/2022 due to a decline in the volatility index.
Brain Scientific Inc. (BRSF) was downgraded to E+ from D- on 10/26/2022 due to a decline in the volatility index.
D
Sell
10/6/2022Upgraded
Brain Scientific Inc. (BRSF) was upgraded to D- from E+ on 10/6/2022 due to an increase in the volatility index.
Brain Scientific Inc. (BRSF) was upgraded to D- from E+ on 10/6/2022 due to an increase in the volatility index.
E
Sell
9/21/2022Downgrade
Brain Scientific Inc. (BRSF) was downgraded to E+ from D- on 9/21/2022 due to a noticeable decline in the growth index, volatility index and total return index. Total revenue declined 75.88% from $159.6 to $38.5, operating cash flow declined 19.07% from -$1.49M to -$1.78M, and EBIT declined 15.7% from -$1.89M to -$2.19M.
Brain Scientific Inc. (BRSF) was downgraded to E+ from D- on 9/21/2022 due to a noticeable decline in the growth index, volatility index and total return index. Total revenue declined 75.88% from $159.6 to $38.5, operating cash flow declined 19.07% from -$1.49M to -$1.78M, and EBIT declined 15.7% from -$1.89M to -$2.19M.
D
Sell
5/20/2022Upgraded
Brain Scientific Inc. (BRSF) was upgraded to D- from E+ on 5/20/2022 due to a substantial increase in the growth index and total return index. Total revenue increased 161.13% from -$261.1 to $159.6, EBIT increased 71.68% from -$6.69M to -$1.89M, and operating cash flow increased 67.94% from -$4.66M to -$1.49M.
Brain Scientific Inc. (BRSF) was upgraded to D- from E+ on 5/20/2022 due to a substantial increase in the growth index and total return index. Total revenue increased 161.13% from -$261.1 to $159.6, EBIT increased 71.68% from -$6.69M to -$1.89M, and operating cash flow increased 67.94% from -$4.66M to -$1.49M.
E
Sell
4/18/2022Downgrade
Brain Scientific Inc. (BRSF) was downgraded to E+ from D- on 4/18/2022 due to a significant decline in the growth index. Operating cash flow declined 1,361.57% from -$318.8 to -$4.66M, EBIT declined 1,126.51% from -$545.5 to -$6.69M, and earnings per share declined from -$0.0204 to -$0.1049.
Brain Scientific Inc. (BRSF) was downgraded to E+ from D- on 4/18/2022 due to a significant decline in the growth index. Operating cash flow declined 1,361.57% from -$318.8 to -$4.66M, EBIT declined 1,126.51% from -$545.5 to -$6.69M, and earnings per share declined from -$0.0204 to -$0.1049.
D
Sell
11/17/2021Upgraded
Brain Scientific Inc. (BRSF) was upgraded to D- from E+ on 11/17/2021 due to a noticeable increase in the growth index and volatility index. Earnings per share increased from -$0.0309 to -$0.02, and EBIT increased 12% from -$619.9 to -$545.5.
Brain Scientific Inc. (BRSF) was upgraded to D- from E+ on 11/17/2021 due to a noticeable increase in the growth index and volatility index. Earnings per share increased from -$0.0309 to -$0.02, and EBIT increased 12% from -$619.9 to -$545.5.
E
Sell
11/8/2021Downgrade
Brain Scientific Inc. (BRSF) was downgraded to E+ from D- on 11/8/2021 due to a decline in the volatility index and total return index.
Brain Scientific Inc. (BRSF) was downgraded to E+ from D- on 11/8/2021 due to a decline in the volatility index and total return index.
D
Sell
8/24/2021Upgraded
Brain Scientific Inc. (BRSF) was upgraded to D- from E+ on 8/24/2021 due to a large increase in the growth index, solvency index and valuation index. Total revenue increased 91.72% from $117.2 to $224.7, earnings per share increased from -$0.1626 to -$0.03, and the quick ratio increased from 0.01 to 0.02.
Brain Scientific Inc. (BRSF) was upgraded to D- from E+ on 8/24/2021 due to a large increase in the growth index, solvency index and valuation index. Total revenue increased 91.72% from $117.2 to $224.7, earnings per share increased from -$0.1626 to -$0.03, and the quick ratio increased from 0.01 to 0.02.
E
Sell
5/25/2021Downgrade
Brain Scientific Inc. (BRSF) was downgraded to E+ from D- on 5/25/2021 due to a large decline in the growth index and solvency index. Earnings per share declined from -$0.0292 to -$0.1626, the quick ratio declined from 0.05 to 0.01, and EBIT declined 42.17% from -$563 to -$800.4.
Brain Scientific Inc. (BRSF) was downgraded to E+ from D- on 5/25/2021 due to a large decline in the growth index and solvency index. Earnings per share declined from -$0.0292 to -$0.1626, the quick ratio declined from 0.05 to 0.01, and EBIT declined 42.17% from -$563 to -$800.4.
D
Sell
2/25/2021Upgraded
Brain Scientific Inc. (BRSF) was upgraded to D- from E+ on 2/25/2021 due to an increase in the total return index.
Brain Scientific Inc. (BRSF) was upgraded to D- from E+ on 2/25/2021 due to an increase in the total return index.
E
Sell
12/1/2020Upgraded
Brain Scientific Inc. (BRSF) was upgraded to E+ from E on 12/1/2020 due to an increase in the volatility index and valuation index.
Brain Scientific Inc. (BRSF) was upgraded to E+ from E on 12/1/2020 due to an increase in the volatility index and valuation index.
E
Sell
9/1/2020Upgraded
Brain Scientific Inc. (BRSF) was upgraded to E from E- on 9/1/2020 due to a noticeable increase in the growth index and valuation index. Operating cash flow increased 35.87% from -$252.3 to -$161.8, and EBIT increased 21.75% from -$452 to -$353.7.
Brain Scientific Inc. (BRSF) was upgraded to E from E- on 9/1/2020 due to a noticeable increase in the growth index and valuation index. Operating cash flow increased 35.87% from -$252.3 to -$161.8, and EBIT increased 21.75% from -$452 to -$353.7.
E
Sell
6/11/2020None
Brain Scientific Inc. (BRSF) was downgraded to E- from U on 06/11/2020.
Brain Scientific Inc. (BRSF) was downgraded to E- from U on 06/11/2020.
OTC PK
08/08/2023 10:45AM Eastern
Quotes delayed
